Xenon Pharmaceuticals
XENE
XENE
153 hedge funds and large institutions have $1.96B invested in Xenon Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 41 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
2% more funds holding
Funds holding: 150 → 153 (+3)
0.13% less ownership
Funds ownership: 93.49% → 93.36% (-0.13%)
74% less call options, than puts
Call options by funds: $1.63M | Put options by funds: $6.25M
Holders
153
Holding in Top 10
9
Calls
$1.63M
Puts
$6.25M
Top Buyers
| 1 | +$29.6M | |
| 2 | +$26.7M | |
| 3 | +$26.4M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$18.1M |
| 5 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$16.9M |
Top Sellers
| 1 | -$30.3M | |
| 2 | -$25.2M | |
| 3 | -$18.3M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$13.7M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$10.4M |